(Q40895421)

24 September 2017

Activation of nuclear factor kappaB in hepatitis C virus infection: implications for pathogenesis and hepatocarcinogenesis (English)

1 reference

24 September 2017

0 references

1 reference

11

Liaw YF

0 references

author name string

Tai DI

1

1 reference

24 September 2017

Tsai SL

2

1 reference

24 September 2017

Chen YM

3

1 reference

24 September 2017

Chuang YL

4

1 reference

24 September 2017

Peng CY

5

1 reference

24 September 2017

Sheen IS

6

1 reference

24 September 2017

Yeh CT

7

1 reference

24 September 2017

Chang KS

8

1 reference

24 September 2017

Huang SN

9

1 reference

24 September 2017

Kuo GC

10

1 reference

24 September 2017

language of work or name

English

0 references

publication date

1 March 2000

1 reference

24 September 2017

1 reference

24 September 2017

31

1 reference

24 September 2017

656-664

1 reference

24 September 2017

3

1 reference

Distinct functional properties of IkappaB alpha and IkappaB beta

24 September 2017

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

Effects of cycloheximide on B-chronic lymphocytic leukaemic and normal lymphocytes in vitro: induction of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

HLA-DR5 antigen. A genetic factor influencing the outcome of hepatitis C virus infection?

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

An assay for circulating antibodies to a major etiologic virus of human non-A, non-B hepatitis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

The molecular virology of hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Transcriptional regulation of cellular and viral promoters by the hepatitis C virus core protein

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Hepatitis C virus core protein interacts with the cytoplasmic tail of lymphotoxin-beta receptor

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Direct interaction of hepatitis C virus core protein with the cellular lymphotoxin-beta receptor modulates the signal pathway of the lymphotoxin-beta receptor

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Hepatitis C virus core protein binds to the cytoplasmic domain of tumor necrosis factor (TNF) receptor 1 and enhances TNF-induced apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Lymphotoxin-beta receptor signaling complex: role of tumor necrosis factor receptor-associated factor 3 recruitment in cell death and activation of nuclear factor kappaB

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

The tumor necrosis factor ligand and receptor families.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Apoptosis and disease: regulation and clinical relevance of programmed cell death

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Even viruses can learn to cope with stress

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Apoptosis regulators from DNA viruses.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Anti-apoptotic strategies of lymphotropic viruses

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Suppression of apoptotic cell death by hepatitis C virus core protein

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Inhibition of tumor necrosis factor (TNF-alpha)-mediated apoptosis by hepatitis C virus core protein

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

An essential role for NF-kappaB in preventing TNF-alpha-induced cell death

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Suppression of TNF-alpha-induced apoptosis by NF-kappaB

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Differential subcellular localization of hepatitis C virus core gene products

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Detection of type 2-like T-helper cells in hepatitis C virus infection: implications for hepatitis C virus chronicity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Clinical applications of TNF-alpha in cancer

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Evidence for the involvement of endothelial cell integrin alphaVbeta3 in the disruption of the tumor vasculature induced by TNF and IFN-gamma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Helicobacter pylori infection activates NF-kappa B in gastric epithelial cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Nuclear factor-kappaB: a pivotal transcription factor in chronic inflammatory diseases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

IEX-1L, an apoptosis inhibitor involved in NF-kappaB-mediated cell survival

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

NF-kappaB antiapoptosis: induction of TRAF1 and TRAF2 and c-IAP1 and c-IAP2 to suppress caspase-8 activation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

The NF-kappa B and I kappa B proteins: new discoveries and insights

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Sensitization to Fas-mediated apoptosis by hepatitis C virus core protein

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

The adenovirus E3-10.4K/14.5K complex mediates loss of cell surface Fas (CD95) and resistance to Fas-induced apoptosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

The pathology of hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Histopathology and pathobiology of hepatotropic virus-induced liver injury

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Apoptosis and viral hepatitis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Ectopic expression of hepatitis C virus core protein differentially regulates nuclear transcription factors

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Suppression of actinomycin D-induced apoptosis by the NS3 protein of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Mechanisms of cycloheximide-induced apoptosis in liver cells

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Acute exacerbations in chronic hepatitis C: a clinicopathological and prognostic study.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

The natural history of community-acquired hepatitis C in the United States. The Sentinel Counties Chronic non-A, non-B Hepatitis Study Team

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Defective TNF-alpha-induced apoptosis in STAT1-null cells due to low constitutive levels of caspases

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

How cells respond to interferons

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Hepatitis C and hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

The mechanisms of chronicity in hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Possible mechanism involving T-lymphocyte response to non-structural protein 3 in viral clearance in acute hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Different clinical behaviors of acute hepatitis C virus infection are associated with different vigor of the anti-viral cell-mediated immune response

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Quantitative analysis of the peripheral blood cytotoxic T lymphocyte response in patients with chronic hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Differential cytotoxic T-lymphocyte responsiveness to the hepatitis B and C viruses in chronically infected patients

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Impaired induction of cytotoxic T lymphocytes by antagonism of a weak agonist borne by a variant hepatitis C virus epitope

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Hepatitis C virus variants circumventing cytotoxic T lymphocyte activity as a mechanism of chronicity

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

HLA DRB1 and DQB1 alleles and haplotypes influencing the progression of hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Genes of the major histocompatibility complex class II influence the outcome of hepatitis C virus infection

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Genetic heterogeneity of hepatitis C virus: quasispecies and genotypes

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Cell cycle control and cancer

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Requirement of NF-kappaB activation to suppress p53-independent apoptosis induced by oncogenic Ras.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-kappaB

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Apoptosis and the liver: A mechanism of disease, growth regulation, and carcinogenesis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Hepatitis C virus core protein inhibits Fas- and tumor necrosis factor alpha-mediated apoptosis via NF-kappaB activation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.510310316

7 January 2021

Identifiers

DOI

10.1002/HEP.510310316

1 reference

24 September 2017

1 reference